Add Yahoo as a preferred source to see more of our stories on Google. Despite highly effective HIV prevention drugs on the market, only a fraction of those at risk in the U.S. are taking them — or ...
University of Utah biochemist Wesley Sundquist achieved yet another milestone last week when the Food and Drug Administration approved an antiviral drug for HIV prevention based on his findings.
The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread among ...
40 million people live with HIV globally, and that number continues to rise. While therapies exist to reduce the amount of HIV in a patient's body and, in turn, reduce HIV symptoms, there remains no ...
A few weeks ago, Grant Ogren and Rhea Ashby-Durall, the executive director and the outreach manager of SAN (formerly Spokane AIDS Network), met with their representative from Gilead Sciences, the ...
Discover how UCSF is leading the charge in Long COVID research, uncovering key findings that advance our understanding of the ...
The U.S. announced Thursday that it will make an investment in the new HIV prevention drug called lenacapavir that’s been hailed as a “breakthrough” and a “game changer” by the medical community. The ...
Forbes contributors publish independent expert analyses and insights. I am a cable news contributor and professor of journalism. Female doctor with red ribbon. Cancer concept. Doctor Holds Red Ribbon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results